AXSM Axsome Therapeutics, Inc. Quarterly EPS earnings growth

Public company logo of Axsome Corp (AXSM)

Patent protection and stringent FDA requirements create a robust barrier to entry for competitors, as evidenced by the quarterly change in earnings per share. 74.50 shapes the current metric. Stable demand for neuromedicine ensures predictable revenue, while the commercialization of Auvelity and the success of new CNS molecules provide powerful operating leverage for profit growth for Axsome Therapeutics (AXSM).

AXSM: Axsome Year-over-year earnings per one share growth for the last 12 months 07/04/2022 - 11/11/2026

Axsome Corp (AXSM) - metric breakdowns and financial figures

- market value and analyst target forecast:
Price Chart Axsome Therapeutics, Inc.|AXSM - Consensus Target
- market capitalization data:
Market Capitalization Axsome Therapeutics Inc|AXSM - Total Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share Axsome Therapeutics|AXSM - Accounting Value of Company|Market Cap to Net Assets Ratio axsome.com|AXSM - Aggregate Business Assets
- company liabilities and liquidity data:
Total Debt to Capital Axsome Therapeutics|AXSM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Axsome Therapeutics|AXSM - Company Cumulative Debt|Debt to Book Capitalization Ratio Axsome Therapeutics Inc|AXSM - Company Long-Term Loans and Borrowings|Company Short-Term Debts Axsome Therapeutics|Quick Liquidity axsome.com
- earnings and valuation multiples information:
AXSM - Profit After Tax|Projected Future Earnings Axsome Therapeutics|AXSM - Market Cap to Earnings|Projected Price to Earnings Axsome Therapeutics Inc|AXSM - PEG Multiple|Enterprise Value to EBITDA Ratio Axsome Therapeutics Inc|AXSM - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Axsome Therapeutics|AXSM - Net earnings per share for the last four quarters|Quarterly EPS earnings growth axsome.com|AXSM - Net earnings per share growth this year|Net earnings per share growth forecast for next year Axsome Therapeutics
Comprehensive company analysis:Axsome Therapeutics
Flagship merchandise of Axsome Corp

Axsome Therapeutics (AXSM) is actively strengthening its position in CNS therapy by bringing innovative migraine and depression treatments to market. Earnings per share dynamics measure the quarterly net income growth rate relative to the previous period. This metric allows for an assessment of business scaling efficiency and the actual monetization of developments. Growth in this indicator signals the company's transition to a stage of sustainable profitability. By analyzing the quarterly EPS gap, an investor can identify fundamental shifts in capitalization in advance.

Who Axsome Therapeutics competes with

Biogen (BIIB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Neurocrine|RGC (Regencell) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ACADIA Corp ACAD|Year-over-year net earnings per share growth for the last 12 months XENE (Xenon Pharmaceuticals)|VKTX (vikingtherapeutics.com) - Year-over-year earnings per one share growth for the last 12 months|Supernus - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months CPRX (Catalyst Pharma)|Denali Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months HRMY (Harmony Corp)|BHVN: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months amylyx.com (AMLX)|Year-over-year earnings per share growth for the last twelve months Trevi Therapeutics, Inc.|PRAX: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AVXL|Quarterly EPS earnings growth CeriBell EEG (CBLL)|Year-over-year earnings per share growth for the last twelve months Prothena Corporation PRTA|ALEC (Alector Inc.) - Year-over-year net earnings per share trend for the last twelve months|Annexon - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Omeros Corporation|NGNE (Neurogene Corp) - Year-over-year net earnings per share growth for the last 12 months|AC Immune Inc (ACIU) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months VYGR|NMRA (neumoratx.com) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth SCLX|Year-over-year net earnings per share change for the last twelve months Tevogen Bio Holdings Inc.|Quarterly EPS earnings growth ACOG (Alpha Cognition Inc.)|CGTX - Year-over-year net earnings per share growth for the last 12 months|IKT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months cassavasciences.com SAVA|ASRT: Quarterly EPS earnings growth|Coya Therapeutics (COYA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months VTGN|Year-over-year earnings per share growth for the last 12 months OVID (Ovid Rx)|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals (ABOS)|Year-over-year net earnings per share change for the last twelve months cervomed.com|Year-over-year earnings per share growth for the last twelve months Alterity Therapeutics Limited ATHE|CLNN - Year-over-year net earnings per share growth for the last 12 months|PEPG - Year-over-year earnings per share growth for the last twelve months|JUNS (jupiterneurosciences.com) - Year-over-year earnings per share growth for the last 12 months|RLMD: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months annovisbio.com (ANVS)|Year-over-year net earnings per share growth for the last 12 months GRCE|Quarterly EPS earnings growth Firefly Neuroscience, Inc.|Year-over-year earnings per share growth for the last twelve months Klotho Neurosciences Inc (KLTO)|NRSN (neurosense-tx.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Reviva Pharmaceuticals RVPH|MetaVia Inc. (MTVA) - Earnings per share growth in annualized terms for the last twelve months|NeurAxis - Quarterly EPS earnings growth|HSDT - Quarterly EPS earnings growth|PASG (passagebio.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months NEUP|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences|athira.com (ATHA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Addex Therapeutics Ltd (ADXN)|ALZN - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cyclerion Therapeutics, Inc. CYCN|PTIX - Year-over-year net earnings per share growth for the last 12 months|Pasithea - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Cortigent, Inc.|ATXI (Avenue Therapeutics, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|CHRO (Chromocell) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth ELYM|ITCI (intracellulartherapies.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals, Inc.)|Marinus Pharmaceuticals Inc (MRNS) - Earnings per share growth in annualized terms for the last twelve months|NKGN - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months NRBO (NeuroBo Pharma)|SAGE: Quarterly EPS earnings growth|synaptogen.com (SNPX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Trevena|Vigil Neuro - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth WENA|CERE - Earnings per share growth in annualized terms for the last twelve months